Company Overview and News

 
Steelco Gujarat: Focus on results

2017-12-27 thehindubusinessline
The board of directors of Steelco Gujarat will meet on Thursday to declare its quarterly results ending September 2017.

 
Steelco Gujarat: eyes on capacity expansion

2017-06-01 thehindubusinessline
Steelco Gujarat has commenced commercial production of a new colour coating line from June 1. In a post-market-hours disclosure to the exchanges, the company said the new product — pre-painted galvanised iron (PPGI) coils and sheets — will enhance its capacity to 60,000 tonnes per annum. Investors will closely monitor the development at the company, which is a subsidiary of Spica Investment Ltd, Mauritius, and belongs to the Comcraft Group.

 
Sebi slaps Rs 25 lakh fine on Steelco Gujarat, promoter group

2016-05-03 financialexpress
Markets watchdog Sebi has imposed a penalty of Rs 25 lakh on Steelco Gujarat Ltd and its promoter group Spica Investments for not complying with the minimum public shareholding norms within the mandated timeframe.

 
Steelco Gujarat reports consolidated net loss of Rs 8.64 crore in the December 2015 quarter

2016-02-06 indiainfoline
Sales decline 41.88% to Rs 98.70 crore

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...